查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545622

全球生物电子医学市场：依类型、产品、应用、最终用户和地区预测（~2030年）

Global Bioelectric Medicine Market Research Report Information by Type, by Product, By Application, By End User, By Region - Forecast till 2030
出版日期: | 出版商: Market Research Future | 英文 152 Pages | 订单完成后即时交付

价格

在预测期内，生物电子医学市场规模预计将以 6.53%的年复合成长率成长。

生物电子医疗产业是由全球慢性病盛行率上升以及参与营运商不断增加的策略性举措所推动的。根据世界卫生组织统计，2019年类风湿性关节炎影响了1,800万人，其中70%是女性，其中55%年龄在55岁以上。此外，英国克隆氏症和结肠炎估计，到2022年，英国每 123 人中就有 1 人患有克隆氏症或溃疡性结肠炎。儘管有人担心生物电医疗设备的高成本将阻碍市场成长，但临床试验的扩大和新进入公司的投资增加预计将为该行业提供有利的前景。

区域洞察

北美市场在2022年占据最大市场占有率，为 38.01%，预计到2030年将成长至约 160亿美元，预测期内年复合成长率为 4.71%。预计亚太地区在预测期内也将呈现最高成长率，年复合成长率为 8.99%。

北美生物电子医疗市场的前景仍然光明，预计将持续扩张。对医疗基础设施的投资和对现代医疗解决方案意识的提高预计将进一步推动市场成长。现有企业和新进业者都准备好利用技术进步并抓住这些机会来满足对更好手术结果日益成长的需求。

由于技术进步、医疗成本上升、慢性病盛行率上升，欧洲市场占据第二大市场。此外，德国生物电子医疗市场拥有最大的市场占有率，法国生物电子医疗市场预计将成为欧洲成长最快的市场。

由于患者人数众多、慢性病盛行率不断上升以及有利的监管政策，预计亚太市场将在2023年至2032年期间发展最快。此外，各大公司不断向该地区扩张，加速了该地区市场的成长。预计中国将占最大占有率，印度预计将成为成长最快的市场。

本报告调查了全球生物电医学市场，提供了市场定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区的细分，竞争环境、主要企业概况等彙整资料。

目录

第1章 执行摘要

第2章 市场概述

第3章 研究方法

第4章 市场动态

  • 摘要
  • 促进因素
    • 世界各地慢性病的发生率上升
    • 新进者加强战略力度
  • 抑制因素
    • 与生物电医疗设备相关的高成本
  • 机会
    • 生物电医学临床试验增加
    • 进入者增加了对生物电子医学的投资

第5章 市场因素分析

  • 波特五力分析
  • 新冠肺炎（COVID-19）对市场的影响

第6章 全球生物电子医学市场：依产品

  • 植入式除颤器
  • 心臟节律器
  • 人工耳蜗
  • 脊髓刺激器
  • 深部脑部刺激器
  • 经皮神经电刺激装置
  • 荐神经刺激器
  • 迷走神经刺激器
  • 其他

第7章 全球生物电子医学市场：依类型

  • 植入式电疗装置
  • 无创电疗仪

第8章 全球生物电子医学市场：依应用

  • 心律不整
  • 疼痛管理
  • 感音神经性听损
  • 帕金森氏症
  • 震颤
  • 忧郁症
  • 癫痫
  • 尿失禁及大便失禁
  • 其他

第9章 全球生物电子医学市场：依最终使用者

  • 医院
  • 研究机关
  • 其他

第10章 全球生物电子医学市场：依地区

  • 摘要
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第11章 竞争态势

  • 开发专案数量最多的公司
  • 主要发展/成长策略
  • 主要公司的财务矩阵

第12章 公司简介

  • ABBOTT
  • BOSTON SCIENTIFIC CORPORATION
  • ALEVA NEUROTHERAPEUTICS
  • COCHLEAR LTD.
  • LIVANOVA PLC
  • MEDTRONIC
  • BIOTRONIK
  • CHARCO NEUROTECH
  • NEVRO CORP
  • ELECTROCORE, INC

第13章 附录

Product Code: MRFR/HC/9533-CR

Global Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030

Market Overview

The Bioelectric Medicine Market is expected to expand at a compound annual growth rate (CAGR) of 6.53% over the projected period. The Bioelectric Medicine industry is being driven by rising prevalence of chronic diseases around the world, as well as increased strategic initiatives by industry participants. According to the World Health Organization, 18 million individuals suffered from rheumatoid arthritis in 2019, with 70% of them being women and 55% being over the age of 55. Furthermore, Crohn's & Colitis UK estimated that one in every 123 persons in the UK will have Crohn's disease or ulcerative colitis by 2022. However, the high cost of bioelectric medical devices is projected to hinder global market growth. Nonetheless, expanding clinical trials for bioelectric medicine and increased investment in bioelectric medicine by market participants are expected to generate profitable prospects for the industry.

The increasing prevalence of chronic diseases around the world is considerably contributing to the expansion of bioelectric medicine. Chronic diseases, including chronic pain conditions, neurological disorders, inflammatory diseases, and metabolic disorders, place a significant strain on healthcare systems and have a negative influence on patients' quality of life. Traditional treatment approaches, such as medicines and surgery, may have limited success or carry concerns of side effects for some people. The increasing prevalence of disorders, together with bioelectric medicine's prospective applicability in these circumstances, is driving up demand for bioelectric medicine products. For example, deep brain stimulation (DBS) has been proven to be effective in treating Parkinson's disease symptoms by regulating aberrant neural activity. Similarly, neuromodulation devices such as vagus nerve stimulation (VNS) have showed efficacy in lowering seizure frequency in epilepsy patients. Furthermore, in February 2024, the World Health Organization stated that approximately 50 million individuals worldwide suffer from epilepsy, with nearly 80% living in low- and middle-income nations.

Market Segment insights

Product-wise, the global bioelectric medicine segment includes implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others.

The bioelectric medicine market is divided into two types: implanted electroceutical devices and noninvasive electroceutical devices.

The Bioelectric Medicine Market has been categorized by application, including arrhythmia, pain management, sensorineural hearing loss, Parkinson's disease, tremor, depression, epilepsy, urine and fecal incontinence, among others.

The market is divided into three segments based on the end user: hospitals, research institutes, and others.

Regional insights

The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America's bioelectric medicine market held the greatest market share of 38.01% in 2022 and is expected to reach roughly USD 16.00 billion by 2030, growing at a 4.71% CAGR during the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.99% over the forecast period.

The future for the North American bioelectric medicine market remains positive, with continued expansion expected. Investments in healthcare infrastructure and increased awareness of modern medical solutions are projected to propel market growth even further. Both established firms and new entrants are ready to seize these possibilities, utilizing technological improvements to address the growing need for better surgical outcomes.

Europe's bioelectric medicine market accounted for the second-largest market share due to technological improvements, rising healthcare costs, and an increase in the prevalence of chronic conditions. Furthermore, the Germany bioelectric medicine market is expected to have the greatest market share, with France's bioelectric medicine market forecast to be the fastest expanding market in Europe.

The Asia-Pacific bioelectric medicine market is predicted to develop the fastest between 2023 and 2032 due to its large patient population, increased prevalence of chronic diseases, and favorable regulatory policies. Furthermore, prominent market companies are constantly expanding into this region, accelerating regional market growth. Furthermore, China's bioelectric medicine market held the greatest market share, while India's bioelectric medicine market is expected to be the fastest expanding market in the Asia-Pacific region.

Major Players

Abbott (US), Boston Scientific Corporation (US), Bortnick (Germany), Aleva Neurotherapeutics (Switzerland), Cochlear Ltd. (Australia), LivaNova PLC (UK), Medtronic (Ireland), Charco Neurotech (UK), ElectroCore, Inc. (US), and Nevro Corp (US) are some of the key companies in the Bioelectric Medicine market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF CHRONIC DISEASES ACROSS THE GLOBE
    • 4.2.2 RISING STRATEGIC INITIATIVES BY MARKET PLAYERS
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST ASSOCIATED WITH BIOELECTRIC MEDICINE DEVICES
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING CLINICAL TRIALS FOR BIOELECTRIC MEDICINE
    • 4.4.2 RISING INVESTMENT IN BIOELECTRIC MEDICINE BY MARKET PLAYERS

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL BIOELECTRIC MEDICINE MARKET

6 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT

  • 6.1 OVERVIEW
    • 6.1.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 6.1.2 CARDIAC PACEMAKERS
    • 6.1.3 COCHLEAR IMPLANTS
    • 6.1.4 SPINAL CORD STIMULATORS
    • 6.1.5 DEEP BRAIN STIMULATORS
    • 6.1.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    • 6.1.7 SACRAL NERVE STIMULATORS
    • 6.1.8 VAGUS NERVE STIMULATORS
    • 6.1.9 OTHERS

7 GLOBAL BIOELECTRIC MEDICINE MARKET, BY TYPE

  • 7.1 OVERVIEW
    • 7.1.1 IMPLANTABLE ELECTROCEUTICAL DEVICES
    • 7.1.2 NON-INVASIVE ELECTROCEUTICAL DEVICES

8 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION

  • 8.1 OVERVIEW
    • 8.1.1 ARRHYTHMIA
    • 8.1.2 PAIN MANAGEMENT
    • 8.1.3 SENSORINEURAL HEARING LOSS
    • 8.1.4 PARKINSON'S DISEASE
    • 8.1.5 TREMOR
    • 8.1.6 DEPRESSION
    • 8.1.7 EPILEPSY
    • 8.1.8 URINARY AND FECAL INCONTINENCE
    • 8.1.9 OTHERS

9 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER

  • 9.1 OVERVIEW
    • 9.1.1 HOSPITALS
    • 9.1.2 RESEARCH INSTITUTES
    • 9.1.3 OTHERS

10 GLOBAL BIOELECTRIC MEDICINE MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 FRANCE
    • 10.3.3 UK
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 INDIA
    • 10.4.3 JAPAN
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 MIDDLE EAST
    • 10.5.2 AFRICA
    • 10.5.3 LATIN AMERICA
  • 11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL BIOELECTRIC MEDICINE MARKET
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 PRODUCT LAUNCH
    • 11.6.2 PRODUCT APPROVAL
    • 11.6.3 ACQUISITION
    • 11.6.4 INVESTMENT
    • 11.6.5 EXPANSION
  • 11.7 MAJOR PLAYERS FINANCIAL MATRIX
    • 11.7.1 SALES (USD BILLION),
    • 11.7.2 R&D (USD BILLION),

12 COMPANY PROFILES

  • 12.1 ABBOTT
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL ANALYSIS
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 BOSTON SCIENTIFIC CORPORATION
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 ALEVA NEUROTHERAPEUTICS
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCT OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 KEY STRATEGIES
  • 12.4 COCHLEAR LTD.
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 SWOT ANALYSIS
    • 12.4.6 KEY STRATEGIES
  • 12.5 LIVANOVA PLC
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 KEY STRATEGIES
  • 12.6 MEDTRONIC
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 SWOT ANALYSIS
    • 12.6.6 KEY STRATEGIES
  • 12.7 BIOTRONIK
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 KEY STRATEGIES
  • 12.8 CHARCO NEUROTECH
    • 12.8.1 COMPANY OVERVIEWS
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 KEY STRATEGIES
  • 12.9 NEVRO CORP
    • 12.9.1 COMPANY OVERVIEWS
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 ELECTROCORE, INC
    • 12.10.1 COMPANY OVERVIEWS
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 SWOT ANALYSIS
    • 12.10.6 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN
  • 13.3 AMERICAN PARKINSON DISEASE ASSOCIATION
  • 13.4 PARKINSON'S FOUNDATION
  • 13.5 ANXIETY AND DEPRESSION ASSOCIATION OF AMERICA
  • 13.6 EUROPEAN ALLIANCE AGAINST DEPRESSION
  • 13.7 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS
  • 13.8 THE AFRICAN SOCIETY FOR REGIONAL ANESTHESIA (AFSRA)
  • 13.9 DEEP BRAIN STIMULATION NURSE ASSOCIATION (DBSNA)
  • 13.10 EUROPEAN SOCIETY OF CARDIOLOGY
  • 13.11 THE COCHLEAR IMPLANT GROUP OF INDIA
  • 13.12 AMERICAN COCHLEAR IMPLANT ALLIANCE
  • 13.13 UNITED SPINAL ASSOCIATION
  • 13.14 AMERICAN SPINAL INJURY ASSOCIATION
  • 13.15 NATIONAL SPINAL CORD INJURY ASSOCIATION
  • 13.16 AMERICAN CLINICAL NEUROPHYSIOLOGY SOCIETY.
  • 13.17 EUROPEAN ACADEMY OF NEUROLOGY (EAN)
  • 13.18 CHILD NEUROLOGY SOCIETY.
  • 13.19 AUSTRALIA EPILEPSY SOCIETY
  • 13.20 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 4 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 5 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR CARDIAC PACEMAKERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 6 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR COCHLEAR IMPLANTS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 7 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 9 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 10 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SACRAL NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR VAGUS NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 12 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 14 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE ELECTROCEUTICAL DEVICES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR NON-INVASIVE ELECTROCEUTICAL DEVICES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 17 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR ARRHYTHMIA, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR SENSORINEURAL HEARING LOSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PARKINSON'S DISEASE, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR TREMOR, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 22 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR DEPRESSION, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 23 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR EPILEPSY, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 24 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR URINARY AND FECAL INCONTINENCE, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 25 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 26 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 27 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 28 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 29 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 30 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 31 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 32 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 33 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 34 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 35 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 36 US: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 37 US: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 38 US: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 39 US: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 40 CANADA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 41 CANADA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 42 CANADA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 43 CANADA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 44 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 45 EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 46 EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 47 EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 48 EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 49 GERMANY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 50 GERMANY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 51 GERMANY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 52 GERMANY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 53 FRANCE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 54 FRANCE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 55 FRANCE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 56 FRANCE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 57 UK: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 58 UK: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 59 UK: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 60 UK: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 61 ITALY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 62 ITALY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 63 ITALY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 64 ITALY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 65 SPAIN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 66 SPAIN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 67 SPAIN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 68 SPAIN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 69 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 70 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 71 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 72 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 73 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 74 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 75 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 76 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 77 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 78 CHINA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 79 CHINA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 80 CHINA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 81 CHINA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 82 INDIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 83 INDIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 84 INDIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 85 INDIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 86 JAPAN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 87 JAPAN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 88 JAPAN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 89 JAPAN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 90 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 91 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 92 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 93 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 94 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 95 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 96 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 97 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 98 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 99 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 100 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 101 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 102 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 103 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 104 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 105 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 106 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 107 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 108 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 109 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 110 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 111 AFRICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 112 AFRICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 113 AFRICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 114 AFRICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 115 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 116 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 117 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 118 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 119 MAJOR PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
  • TABLE 120 MOST ACTIVE PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
  • TABLE 121 PRODUCT LAUNCH
  • TABLE 122 PRODUCT APPROVAL
  • TABLE 123 ACQUISITION
  • TABLE 124 INVESTMENT
  • TABLE 125 EXPANSION
  • TABLE 126 ABBOTT: PRODUCTS OFFERED
  • TABLE 127 ABBOTT: KEY DEVELOPMENTS
  • TABLE 128 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 129 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 130 ALEVA NEUROTHERAPEUTICS: PRODUCT OFFERED
  • TABLE 131 ALEVA NEUROTHERAPEUTICS: KEY DEVELOPMENTS
  • TABLE 132 COCHLEAR LTD.: PRODUCTS OFFERED
  • TABLE 133 COCHLEAR LTD.: KEY DEVELOPMENTS
  • TABLE 134 LIVANOVA PLC: PRODUCTS OFFERED
  • TABLE 135 LIVANOVA PLC: KEY DEVELOPMENTS
  • TABLE 136 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 137 MEDTRONIC.: KEY DEVELOPMENTS
  • TABLE 138 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 139 BIOTRONIK.: KEY DEVELOPMENTS
  • TABLE 140 CHARCO NEUROTECH: PRODUCTS OFFERED
  • TABLE 141 CHARCO NEUROTECH: KEY DEVELOPMENTS
  • TABLE 142 NEVRO CORP: PRODUCTS OFFERED
  • TABLE 143 NEVRO CORP: KEY DEVELOPMENTS
  • TABLE 144 ELECTROCORE, INC: PRODUCTS OFFERED
  • TABLE 145 ELECTROCORE, INC: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL BIOELECTRIC MEDICINE MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BIOELECTRIC MEDICINE MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BIOELECTRIC MEDICINE MARKET
  • FIGURE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
  • FIGURE 9 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2022 & 2032 (USD BILLION)
  • FIGURE 10 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY PRODUCT,
  • FIGURE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
  • FIGURE 12 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2022 & 2032 (USD BILLION)
  • FIGURE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY TYPE,
  • FIGURE 14 GLOBAL BIOELECTRIC MEDICINE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
  • FIGURE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
  • FIGURE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY APPLICATION,
  • FIGURE 17 GLOBAL BIOELECTRIC MEDICINE MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
  • FIGURE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2022 & 2032 (USD BILLION)
  • FIGURE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY END USER,
  • FIGURE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2032 (USD BILLION)
  • FIGURE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION,
  • FIGURE 22 NORTH AMERICA MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
  • FIGURE 23 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
  • FIGURE 24 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
  • FIGURE 25 EUROPE MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
  • FIGURE 26 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
  • FIGURE 27 EUROPE: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
  • FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
  • FIGURE 29 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
  • FIGURE 30 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
  • FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
  • FIGURE 32 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2032 (USD BILLION)
  • FIGURE 33 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION,
  • FIGURE 34 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 35 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
  • FIGURE 36 GLOBAL BIOELECTRIC MEDICINE MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 37 SALES,
  • FIGURE 38 R&D,
  • FIGURE 39 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 ABBOTT: SWOT ANALYSIS
  • FIGURE 41 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 43 COCHLEAR LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 44 COCHLEAR LTD.: SWOT ANALYSIS
  • FIGURE 45 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 46 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 48 NEVRO CORP: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 49 ELECTROCORE, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 ELECTROCORE, INC: SWOT ANALYSIS